Overview

Inhaled Tacrolimus, Add-on to Inhaled Corticosteroids & Long Acting B2 Agonists in Moderate to Severe Persistent Asthma

Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety of tacrolimus in patients with asthma.
Phase:
Phase 2
Details
Lead Sponsor:
Astellas Pharma Inc
Collaborator:
Astellas Pharma Europe B.V.
Treatments:
Tacrolimus